Skip to content

Empowering Equity: Tigerlily Foundation’s Fight Against Breast Cancer Disparities

Tigerlily Foundation is committed to advancing public policy to further our mission to educate, advocate for, empower, and support young women before, during, and after cancer. We are striving to make our vision of ending disparities of age, stage, and color in our lifetime a reality through:

H
E
A
L

We Can HEAL Together:
Legislation & Issues

State Prescription Drug Affordability Boards

Inflation Reduction Act (IRA) Patient Impacts

Policy History
& Impact

Advocacy Tools
and Training

Policy
Events

Tigerlily Foundation has decades of history in the policy landscape. Our goal has always been to advocate for impact by driving policy making to create equity for patients. Patient advocacy leadership has always been key—here within Tigerlily and in guiding public policy. We water the seeds of inspiration and innovation, and working with advocates, advocacy organizations and stakeholders, have created policies and legislation that have changed the lives of millions of people. We are excited to culminate these years of momentum into our Health Equity Advocacy and Leadership (HEAL) Policy Center for Excellence (COE).

1st-block-2048x1363
APPROVED-unsplash9-cropped
Through Tigerlily’s HEAL Policy COE, we work to educate, empower, and lift patient voices to ensure they are amplified, in order to achieve health equity and end disparities. The HEAL Policy COE will focus on systemic changes through policy at the local, state, and federal level to:
 
  • End barriers to accessing and receiving quality, equitable care for all,
  • Lead innovation through patient-leadership, and
  • Achieve health equity and eliminate disparities in breast cancer.

Through the HEAL Policy COE, we seek to influence policy for these purposes through bi-directional learning, programs, and training to cultivate a center to exchange ideas, activate voices and create lasting change.

3rd-block-1024x683-1024x682

To learn more, email HEAL@tigerlilyfoundation.org

Thank You to Our Generous Sponsors

Inspiration Sponsor

HEAL Policy Center of Excellence

Transformational Sponsor

Gilead_PrimaryWhite

Strength Sponsor

Merck_Logo.svg

Beauty Sponsor

astrazeneca-logo
Lilly-Logo
pfizer
phrma-001

Let’s connect on social!

Cover for Tigerlily Foundation
19,386
Tigerlily Foundation

Tigerlily Foundation

Tigerlily Foundation’s mission is to educate, advocate for, empower and support young women before, during and after cancer.

Photos from Valencia McMillan Robinson's post ... See MoreSee Less
View on Facebook
Thank you to everyone who joined us in Atlanta for the Bliss Collective: Brunch & Sip.From the moment we gathered, the space was filled with connection, honesty, and a shared commitment to prioritizing our health and well-being. Your presence helped create an experience rooted in community, empowerment, and meaningful conversation.Swipe through for some of our favorite moments—from powerful stories to impactful discussions on clinical trials, triple-negative breast cancer, survivorship, mental health, wellness, and more—and feel the energy that made this gathering so special.Here’s to continuing to choose Bliss—together. Stay tuned as we bring this experience to more cities.A special thank you to our valued partner, Bristol Myers Squibb, for supporting the Bliss Collective.Photography by Quiet Frame Photography#tlfblissbrunch ... See MoreSee Less
View on Facebook
Missed the webinar? Don’t miss the information. 👇🏽CDK4/6 inhibitors can play a critical role in treatment—but many patients aren’t told about them early enough or don’t know what to ask.This session helps you understand your options and how to speak up with confidence.✔️ What CDK4/6 inhibitors are ✔️ Who they are for ✔️ How they work with hormone therapy ✔️ What to ask your doctorBecause informed patients are empowered patients. 💗🎥 Watch the full webinar recording: youtu.be/-cyaRcx8AsY ... See MoreSee Less
View on Facebook
In case you missed it… this conversation matters more than you think.Too many patients don’t know that CDK4/6 inhibitors are a standard of care—not a last resort.Too many are told to wait… or don’t know what to ask.And sometimes, that delay can change everything.You deserve the right information, the right treatment, and the confidence to advocate for yourself. 💗✨ Swipe to understand your options✨ Save this for later✨ Share to spread awareness🎓 Want to learn more? Our Pull Up a Seat webinar dives deeper into these important conversations. Watch now: youtu.be/-cyaRcx8AsY ... See MoreSee Less
View on Facebook

2 weeks ago

Tigerlily Foundation
We owe it to patients. We owe it to advocates like Ravan Patrick.Read Tigerlily Foundation’s latest opinion editorial on the 340B program in New York—honoring Ravan’s legacy and continuing the work to ensure equitable access to care for breast cancer patients. 💗📰 Read the op-ed: www.syracuse.com/opinion/2026/04/we-owe-it-to-breast-cancer-patients-to-fix-the-340b-drug-program-guest-opinion-by-maimah-karmo.html syracuse.com Maimah Karmo ... See MoreSee Less
View on Facebook